42 results on '"Bosello, Silvia"'
Search Results
2. Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels.
- Author
-
Occhipinti, Mariaelena, Bosello, Silvia, Sisti, Leuconoe Grazia, Cicchetti, Giuseppe, de Waure, Chiara, Pirronti, Tommaso, Ferraccioli, Gianfranco, Gremese, Elisa, and Larici, Anna Rita
- Subjects
- *
INTERSTITIAL lung diseases , *COMPUTED tomography , *SYSTEMIC scleroderma - Abstract
Objectives: To evaluate interstitial lung disease associated with systemic sclerosis (SSc-ILD) and its changes during treatment by using quantitative analysis (QA) compared to semi-quantitative analysis (semiQA) of chest computed tomography (CT) scans. To assess the prognostic value of QA in predicting functional changes. Materials and methods: We retrospectively selected 35 consecutive patients with SSc-ILD with complete pulmonary functional evaluation, Doppler-echocardiography, immunological tests, and chest CT scan at both baseline and follow-up after immunosuppressive therapy. CT images were analyzed by two chest radiologists for semiQA and by a computational platform for texture analysis of ILD patterns (CALIPER) for QA. Concordance between semiQA and QA was tested. Traction bronchiectasis severity was scored. Analysis of ROC curves was performed. Results: Seventy CT scans were analyzed and QA failed in 4/70 scans. Thus, the final population included 31/35 patients (51.3±12.1 years). QA had a weak-to-good concordance with semiQA (ICC reticular:0.275; ICC ground-glass:0.667) and QA correlated better than semiQA (r = -0.3 to -0.74 vs r = -0.3 to -0.4) with functional parameters. Both methods correlated with traction bronchiectases score and pulmonary artery diameter at CT. A pulmonary artery diameter ≥29mm distinguished patients with lower lung volumes and ILD extent greater than 39% (p<0.001). Changes in QA patterns during treatment were not accurate (AUC: 0.50 to 0.70; p>0.05) in predicting disease progression as assessed by functional parameters, whereas variation in total lung volume at QA accurately predicted changes in the composite functional respiratory endpoint with FVC% and DLco% (AUC = 0.74; 95%CI: 0.54 to 0.93; p = 0.03). Conclusions: Pulmonary QA of CT images can objectively quantify specific patterns of ILD changes during treatment in patients with SSc-ILD. Changes in QA patterns do not correlate with functional changes, but variation in total lung volume at QA accurately predicted changes in the composite functional respiratory endpoint with FVC% and DLco%. Pulmonary artery diameter at CT reflects the interstitial involvement, identifying patients with more severe prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
3. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
- Author
-
Bosello, Silvia, De Luca, Giacomo, Berardi, Giorgia, Canestrari, Giovanni, de Waure, Chiara, Gabrielli, Francesca Augusta, Di Mario, Clara, Forni, Franca, Gremese, Elisa, and Ferraccioli, Gianfranco
- Subjects
- *
HEART failure , *SYSTEMIC scleroderma , *HEART diseases , *BRUGADA syndrome , *PULMONARY hypertension , *LONGITUDINAL method - Abstract
Abstract Objectives The aim of our study was to define the role of high-sensitive cardiac troponin T (hs-cTnT) and NT-proBNP in identifying Systemic Sclerosis (SSc) patients with cardiac involvement and at higher risk of cardiac death. Methods Plasma hs-cTnT and NT-proBNP concentrations were measured in 245 SSc-patients. Results hs-cTnT and NT-proBNP levels were higher in SSc-patients than in healthy controls. Hs-cTnT levels were higher than 0.014 ng/ml in 32.3% SSc-patients, while NT-proBNP was above 125 pg/ml in 31.8% of them, irrespective of classical cardiovascular risk factor and of pulmonary arterial hypertension. Elevated hs-cTnT and NT-proBNP were associated with diffuse skin involvement and directly correlated with the skin score. Patients with increased cardiac markers presented a lower left-ventricular ejection fraction (LVEF) and a higher rate of right bundle branch block (RBBB) on electrocardiogram (ECG) compared to patients with normal cardiac enzymes. During the follow-up, 12 SSc-patients experience a disease-related death; 9 of these were directly related to cardiac involvement (sudden cardiac death or heart failure) and the majority of them occurred among patients with increase of at least one cardiac biomarker. Long-term survival was worse in patients with increase of both cardiac biomarkers. Conclusions Evaluation of hs-cTnT and NT-proBNP levels may provide a tool to screen non-invasively SSc-patients for heart involvement. A higher incidence of impaired systolic function, ECG abnormalities and a poor outcome in SSc-patients with elevated cardiac enzymes suggests that they may be valuable screening biomarkers to detect a cardiac damage at early stages and to improve risk stratification. Highlights • Subclinical heart involvement is common in Systemic Sclerosis. • Primary heart involvement portend a dismal prognosis. • hs-cTnT and NT-proBNP are biomarkers of early cardiac damage. • hs-cTnT and NT-proBNP are predictors of poor outcome. • hs-cTnT and NT-proBNP should be measured in all patients with Systemic Sclerosis. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
4. Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome.
- Author
-
De Luca, Giacomo, Bosello, Silvia Laura, Gabrielli, Francesca Augusta, Berardi, Giorgia, Parisi, Federico, Rucco, Manuela, Canestrari, Giovanni, Loperfido, Francesco, Galiuto, Leonarda, Crea, Filippo, and Ferraccioli, Gianfranco
- Subjects
- *
SYSTEMIC scleroderma , *ELECTROCARDIOGRAPHY , *ARRHYTHMIA , *CARDIAC arrest , *IMPLANTABLE cardioverter-defibrillators , *ELECTROPHYSIOLOGY , *PROGNOSIS - Abstract
Background: Arrhythmias are frequent in Systemic Sclerosis (SSc) and portend a bad prognosis, accounting alone for 6% of total deaths. Many of these patients die suddenly, thus prevention and intensified risk-stratification represent unmet medical needs. The major goal of this study was the definition of ECG indexes of poor prognosis. Methods: We performed a prospective cohort study to define the role of 24h-ECG-Holter as an additional risk-stratification technique in the identification of SSc-patients at high risk of life-threatening arrhythmias and sudden cardiac death (SCD). One-hundred SSc-patients with symptoms and/or signs suggestive of cardiac involvement underwent 24h-ECG-Holter. The primary end-point was a composite of SCD or need for implantable cardioverter defibrillator (ICD). Results: Fifty-six patients (56%) had 24h-ECG-Holter abnormalities and 24(24%) presented frequent ventricular ectopic beats (VEBs). The number of VEBs correlated with high-sensitive cardiac troponin T (hs-cTnT) levels and inversely correlated with left-ventricular ejection fraction (LV-EF) on echocardiography. During a mean follow-up of 23.1±16.0 months, 5 patients died suddenly and two required ICD-implantation. The 7 patients who met the composite end-point had a higher number of VEBs, higher levels of hs-cTnT and NT-proBNP and lower LV-EF (p = 0.001 for all correlations). All these 7 patients had frequent VEBs, while LV-EF was not reduced in all and its range was wide. At ROC curve, VEBs>1190/24h showed 100% of sensitivity and 83% of specificity to predict the primary end-point (AUROC = 0.92,p<0.0001). Patients with VEBS>1190/24h had lower LV-EF and higher hs-cTnT levels and, at multivariate analysis, the presence of increased hs-cTnT and of right bundle branch block on ECG emerged as independent predictors of VEBs>1190/24h. None of demographic or disease-related characteristics emerged as predictors of poor outcome. Conclusions: VEBS>1190/24h identify patients at high risk of life-threatening arrhythmic complications. Thus, 24h-ECG-Holter should be considered a useful additional risk-stratification test to select SSc-patients at high-risk of SCD, in whom an ICD-implantation could represent a potential life-saving intervention. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
5. Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk.
- Author
-
De Luca, Giacomo, Bosello, Silvia L., Berardi, Giorgia, Rucco, Manuela, Canestrari, Giovanni, Correra, Miriam, Mirone, Luisa, Forni, Franca, Di Mario, Clara, Danza, Francesco M., Pirronti, Tommaso, and Ferraccioli, Gianfranco
- Subjects
- *
TUMOR risk factors , *TUMOR markers , *ACADEMIC medical centers , *BLOOD testing , *CONFIDENCE intervals , *ENZYME-linked immunosorbent assay , *INTERSTITIAL lung diseases , *LONGITUDINAL method , *MULTIVARIATE analysis , *PATIENT monitoring , *PUBLIC health surveillance , *PULMONARY function tests , *STATISTICS , *SYSTEMIC scleroderma , *LOGISTIC regression analysis , *DATA analysis , *RELATIVE medical risk , *SEVERITY of illness index , *DATA analysis software , *DESCRIPTIVE statistics , *ODDS ratio , *MANN Whitney U Test , *DISEASE complications , *THERAPEUTICS - Abstract
Objective. To evaluate the serum levels of tumour-associated antigens (TAAs) in patients with SSc and interstitial lung disease (ILD) and to define whether their levels mirror the severity and the progression of lung damage. Methods. Data from 80 SSc patients with ILD were collected at baseline and after 2 years as well as from 40 SSc controls without ILD. The occurrence of any malignancy was recorded. Results. At baseline, an increase of at least one TAA was present in 35 SSc patients with ILD compared with 6 SSc patients without ILD (P< 0.0001); this was associated with lower forced vital capacity (FVC) and higher interstitial and alveolar scores. Levels of carbohydrate antigen 15-3 and carcinoembryonic antigen inversely correlated with FVC and directly correlated with alveolar and interstitial scores and their levels were higher in patients who presented a progression of lung damage after 2 years. During 4 years of follow-up, a malignancy was detected in seven patients who already had an increase of at least one TAA. Values of TAAs increased over time in patients who developed cancer, while their trend remained stable in the others. At multivariate analysis, to have three or more TAAs emerged as a strong independent predictor of the development of malignancies [relative risk 24.1 (95% CI 1.8, 315.0), P = 0.02]. Conclusion. TAAs can be elevated in the sera of SSc patients and correlate with the degree of lung damage, suggesting a role as severity biomarkers. Close follow-up is necessary in SSc patients because of the increased cancer risk overall in patients with increased TAAs. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
6. Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease.
- Author
-
De Santis, Maria, Bosello, Silvia Laura, Peluso, Giusy, Pinnelli, Michela, Alivernini, Stefano, Zizzo, Gaetano, Bocci, Mario, Capacci, Annunziata, La Torre, Giuseppe, Mannocci, Alice, Pagliari, Gabriella, Varone, Francesco, Pistelli, Roberto, Danza, Francesco Maria, and Ferraccioli, Gianfranco
- Subjects
- *
BRONCHOALVEOLAR lavage , *IRRIGATION (Medicine) , *SCLERODERMA (Disease) , *DISEASE progression , *LUNG diseases , *MORTALITY , *PATIENTS - Abstract
Introduction: So far no clinical or experimental evidences clearly explain how and which systemic sclerosis (SSc) patients will experience a functional and radiological progression of interstitial lung disease (ILD). Objectives: The aim of the study was to investigate whether any bronchoalveolar lavage fluid (BALF) characteristic, compared with clinical, functional and radiological parameters, is associated with the risk of progression of ILD and worse survival in SSc patients. Methods: Lung involvement was evaluated in 110 consecutively examined SSc patients with pulmonary function tests (PFTs) and high-resolution computed tomography (HRCT); 73 patients with evidence of ILD on HRCT underwent BAL. The progression of ILD was evaluated with PFTs and HRCT after 1-year follow-up. A 36-month survival analysis was assessed. Results: ILD patients with alveolitis had a higher risk to have restrictive lung disease and honeycombing, to experience a worsening in honeycombing score or to develop honeycombing. ILD progression was associated with the evidence of honeycombing on HRCT, with the presence of eosinophils, with an inverted CD4/CD8 ratio and with a higher CD19 percentage count in the BALF or with a positive BALF microbiological culture. The patients with ILD had a worse overall survival. The diffuse disease was the only independent risk factor of overall mortality, and the extent of honeycombing on HRCT was the only independent risk factor of lung disease-related mortality. Conclusion: Our study suggests the importance of evaluating ILD with HRCT and BAL in order to characterize the risk factors of SSc lung involvement progression. Please cite this paper as: De Santis M, Bosello SL, Peluso G, Pinnelli M, Alivernini S, Zizzo G, Bocci M, Capacci A, La Torre G, Mannocci A, Pagliari G, Varone F, Pistelli R, Danza FM and Ferraccioli G. Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease. Clin Respir J 2012; 6; 9-17. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
7. B cells in systemic sclerosis: A possible target for therapy
- Author
-
Bosello, Silvia, De Luca, Giacomo, Tolusso, Barbara, Lama, Gina, Angelucci, Cristiana, Sica, Gigliola, and Ferraccioli, Gianfranco
- Subjects
- *
SYSTEMIC scleroderma , *B cells , *EXTRACELLULAR matrix , *AUTOANTIBODIES , *IMMUNE system , *T cells , *CD antigens , *RITUXIMAB , *CYTOKINES - Abstract
Abstract: Systemic sclerosis (SSc) is an autoimmune disease characterized by excessive extracellular matrix (ECM) deposition in the skin and other visceral organs and it is associated with immune activation characterized by autoantibody production, release of various cytokines and T-lymphocyte activation. Several recent lines of evidence in animal models and in SSc patients indicate a potential role for B cells in the SSc. B cells have arisen as a possible player in tissue fibrosis in some experimental models and, since IL-6 produced by B cells, along with TGF-β, may induce matrix synthesis and less collagen degradation, targeting B cells could be one way to reduce ECM deposition and reduce the inflammatory background. Both SSc patients and tight-skin mice, a genetic model of SSc, have intrinsic B-cell abnormalities characterized by chronic B-cell activation. SSc patients present an increased number of naïve B cells and an activation of memory B cells, despite a reduction in their number. B cells from SSc patients exhibit increased expression of CD19. Remarkably, CD19 loss or B-cell depletion using antimouse CD20 antibody suppresses the development of skin hyperplasia and autoimmunity in tight-skin mice. Additionally, recent studies revealed a possible beneficial effect of anti-human CD20 antibody (Rituximab) therapy on skin fibrosis and lung involvement in SSc patients. These studies reported also the safety of Rituximab in SSc patients. All these findings suggest a possible role of antiCD20 treatment in SSc patients. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
8. TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis.
- Author
-
Bosello, Silvia, Santoliquido, Angelo, Zoli, Angelo, Di Campli, Cristiana, Flore, Roberto, Tondi, Paolo, and Ferraccioli, GianFranco
- Subjects
- *
RHEUMATOID arthritis , *THERAPEUTICS , *CELL communication , *RHEUMATISM , *ULTRASONIC imaging - Abstract
Considerable evidence indicates that patients with rheumatoid arthritis (RA) are at greater risk of developing atherosclerosis and cardiovascular disease. Recent studies support the predictive ability of endothelial function measures for subsequent atherosclerotic events. We have investigated the effects of infliximab, a chimeric monoclonal anti-tumor necrosis factor (TNF) antibody, on endothelial vasodilation, measured by brachial ultrasonography and on the levels of inflammatory biomarkers and adhesion molecules in ten consecutive patients with severe long-standing RA, despite methotrexate therapy, during the loading phase of infliximab therapy. Flow-mediated dilation (FMD) in RA patients at baseline was significantly impaired compared with healthy controls (7.71 ± 2.78% vs 14.91 ± 6.41%; p = 0.008) and improved significantly after infliximab infusion (12.63 ± 1.63% vs 7.71 ± 2.78%; p = 0.005). At baseline, a statistically significant correlation between C-reactive protein levels and FMD was found ( r = −0.69, p = 0.026). However, this improvement was transitory, as FMD values returned to baseline values before each infliximab infusion at weeks 2, 6 and 14. There were no significant differences in baseline brachial artery diameter between visits, although at each time, the diameter was increased. According to European League Against Rheumatism response criteria, all ten patients were good responders. No significant differences were observed in intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, vascular endothelial growth factor and E-selectin plasma levels before and after each infusions. This study demonstrates that endothelial dysfunction is a reversible phenomenon in RA. The addition of anti-TNFα treatment reduces inflammatory symptoms in patients with severe RA. The improvement of endothelial function during the loading phase of therapy is transitory, suggesting an enhanced and persistent TNF-α generation within the arterial wall. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
9. Comment on: Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis.
- Author
-
Bosello, Silvia, Gremese, Elisa, and Ferraccioli, Gianfranco
- Subjects
- *
BIOMARKERS , *RESPIRATORY measurements , *SKIN care , *SYSTEMIC scleroderma , *DISEASE relapse , *DISEASE progression - Published
- 2020
- Full Text
- View/download PDF
10. Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis.
- Author
-
De Santis, Maria, Bosello, Silvia, La Torre, Giuseppe, Capuano, Anna, Tolusso, Barbara, Pagliari, Gabriella, Pistelli, Riccardo, Danza, Francesco Maria, Zoli, Angelo, and Ferraccioli, Gianfranco
- Subjects
- *
ALVEOLITIS , *RESPIRATORY infections , *SYSTEMIC scleroderma , *LUNG diseases , *PATIENTS , *CARDIOPULMONARY system , *PULMONARY function tests , *MEDICAL research - Abstract
Background: A progressive lung disease and a worse survival have been observed in patients with systemic sclerosis and alveolitis. The objective of this study was to define the functional, radiological and biological markers of alveolitis in SSc patients. Methods: 100 SSc patients (76 with limited and 24 with diffuse disease) underwent a multistep assessment of cardiopulmonary system: pulmonary function tests (PFTs) every 6-12 months, echocardiography, high resolution computed tomography (HRCT) and bronchoalveolar lavage (BAL), if clinically advisable. Alveolar and interstitial scores on HRCT and IL-6 plasma levels were also assessed as lung disease activity indices. Results: 90 SSc patients with abnormal PFTs and 3 with signs and/or symptoms of lung involvement and normal PFTs underwent HRCT and echocardiography. HRCT revealed evidence of fibrosis in 87 (93.5%) patients, with 55 (59.1%) showing both ground glass attenuation and fibrosis. In 42 patients who had exhibited ground glass on HRCT and consented to undergo BAL, 16 (38.1%) revealed alveolitis. 12 (75%) of these patients had restrictive lung disease (p < 0.0001) and presented diffuse skin involvement (p = 0.0009). IL-6 plasma levels were higher in patients with alveolitis than in patients without (p = 0.041). On logistic regression model the best independent predictors of alveolitis were diffuse skin involvement (OR(95%CIs):12.80(2.54-64.37)) and skin score > 14 (OR(95%CIs):7.03(1.40-34.33)). The alveolar score showed a significant correlation with IL-6 plasma levels (r = 0.36, p = 0.001) and with the skin score (r = 0.33, p = 0.001). Cultures of BAL fluid resulted positive in 10 (23.8%) of the 42 patients that underwent BAL and after one year a deterioration in PFTs occurred in 8 (80%) of these patients (p = 0.01). Pulmonary artery systolic pressure = 40 mmHg was found in 6 (37.5%) patients with alveolitis. Conclusion: We found alveolitis only in 38.1% of the patients who had exhibited ground glass on HRCT and then underwent BAL, probably because the concomitant fibrosis influenced results. A diffuse skin involvement and a restrictive pattern on PFTs together with ground glass on HRCT were judged possible markers of alveolitis, a BAL examination being indicated as the next step. Nevertheless BAL would be necessary to detect any infections of the lower respiratory tract that may cause further deterioration in lung function. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
11. Significant nailfold capillary loss and late capillaroscopic pattern are associated with pulmonary arterial hypertension in systemic sclerosis.
- Author
-
Angelis, Rossella De, Riccieri, Valeria, Cipolletta, Edoardo, Papa, Nicoletta Del, Ingegnoli, Francesca, Bosello, Silvia, Spinella, Amelia, Pellegrino, Greta, Pinto, Marco de, Papa, Silvia, Armentaro, Giuseppe, and Giuggioli, Dilia
- Subjects
- *
PULMONARY hypertension diagnosis , *CAPILLARIES , *CROSS-sectional method , *ANGIOSCOPY , *NAILS (Anatomy) , *DESCRIPTIVE statistics , *CHI-squared test , *ODDS ratio , *SYSTEMIC scleroderma , *CASE-control method , *RESEARCH , *CARDIOVASCULAR system physiology , *CONFIDENCE intervals , *BIOMARKERS , *DISEASE complications - Abstract
Objective To evaluate differences in nailfold videocapillaroscopy (NVC) findings between SSc patients with and without a diagnosis of pulmonary arterial hypertension (PAH). Methods One hundred and ten SSc patients were enrolled in this cross-sectional, case–control, multicentre study. Patients were divided into cases (SSc-PAH confirmed by right heart catheterization) and controls (SSc-nonPAH with low probability of PAH). NVC patterns (early, active and late) and morphological parameters (microvascular density, non-specific abnormalities, giant capillaries, micro-haemorrhages, avascular areas) were considered using a semiquantitative scoring system. Results SSc-PAH patients showed higher frequencies of late pattern (P < 0.01), non-specific abnormalities (P < 0.01), lower capillary density (P < 0.01), higher avascular areas (P < 0.01) and a higher mean NVC score (P < 0.01). Contrarily, the early/active pattern (P < 0.01) and a higher rate of micro-haemorrhages (P = 0.04) were more frequent in non-PAH patients. By a multivariate analysis, SSc-PAH patients, compared with non-PAH, had more non-specific abnormalities [27/55, 49.1% vs 10/55, 18.2%; adjusted odd ratio (OR) 16.89; 95% CI: 3.06, 93.16], a lower capillary density (grade 3, 20/55, 36.4% vs 5/55, 9.1%; adjusted OR 38.33; 95% CI: 2.34, 367.80) and avascular areas (18/55, 32.7% vs 10/55, 18.2%; adjusted OR 16.90; 95% CI: 2.64, 44.35). A correlation was found between the mean pulmonary arterial pressure and avascular areas (P < 0.01), capillary density (P < 0.01) and non-specific abnormalities (P < 0.01). A clinical model including the NVC variables may be able to predict a diagnosis of PAH. Conclusion Our results indicate that the distinctive peripheral microcirculatory injury of SSc, i.e. capillary loss and morphological abnormalities, appear more severe and pronounced in patients with SSc-PAH. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement.
- Author
-
De Lorenzis, Enrico, Bosello, Silvia Laura, Varone, Francesco, Sgalla, Giacomo, Calandriello, Lucio, Natalello, Gerlando, Iovene, Bruno, Cicchetti, Giuseppe, Gigante, Laura, Verardi, Lucrezia, Gremese, Elisa, Richeldi, Luca, and Larici, Anna Rita
- Subjects
- *
RHEUMATOLOGISTS , *RHEUMATISM , *PULMONOLOGISTS , *AUTOIMMUNE diseases , *INTERSTITIAL lung diseases - Abstract
Multidisciplinary team (MDT) discussion is the gold standard in the management of interstitial lung disease (ILD). The rheumatologist is not routinely involved in MDT, even if up to 20% of ILD are related to systemic autoimmune rheumatic diseases (SARD). The study aims to assess the agreement and its variation over time between rheumatologists and pulmonologists in the screening of SARD and between rheumatologists and an MDT extended to rheumatologists (eMDT) in evaluating the progression of SARD. We computed the agreement between the pulmonologist and rheumatologist in the identification of red flags for SARDs of 81 ILD cases and between the rheumatologist alone and eMDT in the confirmation of 70 suspected SARD-ILD progressions. The agreement between rheumatologists and pulmonologists was moderate for the detection of autoimmunity test positivity (κ = 0.475, p < 0.001) and family history of SARD (κ = 0.491, p < 0.001) and fair for the identification of extrapulmonary symptoms (κ = 0.225, p = 0.064) or routine laboratory abnormalities consistent with SARD. The average agreement between the rheumatologist and eMDT in the identification of ILD progression was moderate (κ = 0.436, p < 0.001). The class of agreement improved from the first to the third semester. The average agreement with the rheumatologist ranged from fair to moderate, suggesting that a shared evaluation of SARD-ILD in eMDT could improve the diagnostic work-up and the evaluation of ILD progression. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
13. Tumor Necrosis Factor-a Inhibitor Therapy in Erosive Polyarthritis Secondary to Systemic Sclerosis.
- Author
-
Bosello, Silvia, de Santis, Maria, Tolusso, Barbara, Zoli, Angelo, and Ferraccioli, Gianfranco
- Subjects
- *
LETTERS to the editor , *TUMOR necrosis factors - Abstract
A letter to the editor is presented in response to an article related to tumor necrosis factor-α inhibitors therapy.
- Published
- 2005
- Full Text
- View/download PDF
14. Troponin in Stable Ischemic Heart Disease and Diabetes.
- Author
-
Bosello, Silvia, De Luca, Giacomo, and Ferraccioli, Gianfranco
- Subjects
- *
TROPONIN , *HEART disease diagnosis , *CLINICAL medicine - Abstract
A letter to the editor is presented in response to a study by B. M. Everett and colleagues which reported increased level of high-sensitivity cardiac troponin T in patients with both type 2 diabetes and ischemic heart disease.
- Published
- 2015
- Full Text
- View/download PDF
15. Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients.
- Author
-
Caimmi, Cristian, De Marchi, Sergio, Bosello, Silvia Laura, Giuggioli, Dilia, Caramaschi, Paola, Di Giorgio, Angela, Spinella, Amelia, Astorino, Giulia, Canestrari, Giovanni, Cocchiara, Emanuele, Gremese, Elisa, Viapiana, Ombretta, and Rossini, Maurizio
- Subjects
- *
SYSTEMIC scleroderma , *LEG , *ARM , *CARDIOVASCULAR diseases risk factors , *DOPPLER ultrasonography , *ATHEROSCLEROTIC plaque - Abstract
Objectives: Data on macrovascular involvement in systemic sclerosis (SSc) are still debatable. The aim of this study was to estimate its prevalence and possible determinants in a large cohort. Methods: One hundred and fifty‐five outpatients with SSc were enrolled. Data about disease characteristics and cardiovascular risk factors were collected and patients underwent ecocolor Doppler ultrasonography of arteries of the neck and lower (LL) and upper (UL) limbs. Results: Mean age was 57.9 ± 14.5 years and most were female (88.4%) with a limited subset (63.2%). Mean disease duration was 11.4 ± 8.1 years. Twenty‐three (14.8%) had hypertension, 7 (4.8%) diabetes, 64 (41.3%) hypercholesterolemia and 63 (40.6%) were active/past smokers. Seventy‐nine (49%) patients had plaques at carotids, 49 (32.9%) at LL and 7 (4.9%) at UL. In multivariate analysis, patients with carotid plaques had more often a limited pattern (P =.001), patients with distal LL plaques pulmonary arterial hypertension (P =.006) and patients with proximal LL plaques lower diffusing capacity for carbon monoxide adjusted to hemoglobin and its ratio to alveolar volume (P =.004). In patients with UL plaques traditional cardiovascular risk factors were not more common, while forced vital capacity was lower (P =.023). Finally, upper limb and proximal LL plaques were as common in early disease patients as in longstanding ones, although the former were younger. Conclusions: This study shows that macrovascular involvement is quite common in SSc and that some disease characteristics linked to microvascular involvement are associated with atherosclerotic plaques, which can be present even in early disease. Our study suggests that a complete evaluation of macrocirculation is mandatory for rheumatologists treating SSc patients. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
16. QTc interval prolongation in Systemic Sclerosis: Correlations with clinical variables and arrhythmic risk.
- Author
-
De Luca, Giacomo, Bosello, Silvia Laura, Canestrari, Giovanni, Cavalli, Giulio, Dagna, Lorenzo, and Ferraccioli, Gianfranco
- Subjects
- *
SYSTEMIC scleroderma , *ARRHYTHMIA , *DISEASE risk factors - Published
- 2017
- Full Text
- View/download PDF
17. Microvascular heart involvement in systemic autoimmune diseases: The purinergic pathway and therapeutic insights from the biology of the diseases.
- Author
-
De Lorenzis, Enrico, Gremese, Elisa, Bosello, Silvia, Nurmohamed, Michael Tuahier, Sinagra, Gianfranco, and Ferraccioli, Gianfranco
- Subjects
- *
HEART failure , *AUTOIMMUNE diseases , *BIOLOGY , *ACUTE coronary syndrome , *ARRHYTHMIA , *CORONARY disease , *HEART - Abstract
Heart involvement – often asymptomatic – is largely underestimated in patients with systemic autoimmune diseases (SADs). Cardiovascular events are more frequent in patients with SADs compared to the general population, owing to the consequences of inflammation and autoimmunity and to the high prevalence of traditional risk factors. Coronary microvascular disease (CMD) is a form of cardiac involvement that is increasingly recognised yet still largely neglected. CMD, the incapacity of the coronary microvascular tree to dilate when myocardial oxygen demand increases or when there is a microvascular spasm (or subclinical myocarditis), is increasingly reported because of the widespread use of new cardiac imaging tools, even in a subclinical phase. The assessment of myocardial coronary flow reserve (CFR) emerged as the most effective clinical tool to detect microvascular damage. The potential causes of microvascular damage, molecular and cellular inflammation along with a pathological CD39-CD73 axis, need always to be considered because data show that they play a role in the occurrence of acute coronary syndromes, heart failure and arrhythmias, even in the early asymptomatic stage. Data suggest that controlling disease activity by means of methotrexate, biologic drugs, antimalarial medications, statins and aspirin, according to indication, might reduce the cardiovascular risk related to macrovascular and microvascular damage in most patients with SADs, provided that they are used early and timely to control diseases. The need of new biomarkers and a careful assessment of myocardial CFR emerged as the most effective clinical tool to detect microvascular damage. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
18. Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients.
- Author
-
Cacciapaglia, Fabio, Airò, Paolo, Fornaro, Marco, Trerotoli, Paolo, Lorenzis, Enrico De, Corrado, Addolorata, Lazzaroni, Maria Grazia, Natalello, Gerlando, Montini, Fabio, Altomare, Alberto, Urso, Livio, Verardi, Lucrezia, Bosello, Silvia Laura, Cantatore, Francesco Paolo, and Iannone, Florenzo
- Subjects
- *
SURVIVAL , *PULMONARY arterial hypertension , *CONFIDENCE intervals , *SYSTEMIC scleroderma , *INTERSTITIAL lung diseases , *DESCRIPTIVE statistics - Abstract
Objectives Survival and death prognostic factors of SSc patients varied during the past decades. We aimed to update the 5- and 10-year survival rates and identify prognostic factors in a multicentre cohort of Italian SSc patients diagnosed after 2009. Material and methods Patients who received a diagnosis of SSc after 1 January 2009 and were longitudinally followed up in four Italian rheumatologic centres were retrospectively assessed up to 31 December 2020. Overall survival of SSc patients was described using the Kaplan–Meier method. Predictors of mortality at 10-year follow-up were assessed by the Cox regression model. A comparison of our cohort with the Italian general population was performed by determining the standardized mortality ratio (SMR). Results A total of 912 patients (91.6% females, 20% dcSSc) were included. Overall survival rates at 5 and 10 years were 94.4% and 89.4%, respectively. The SMR was 0.96 (95% CI 0.81, 1.13), like that expected in the Italian general population. Pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD) associated with pulmonary hypertension (PH) significantly reduced survival (P < 0.0001). Main death predictors were male gender (HR = 2.76), diffuse cutaneous involvement (HR = 3.14), older age at diagnosis (HR = 1.08), PAH (HR = 3.21), ILD-associated PH (HR = 4.11), comorbidities (HR = 3.53) and glucocorticoid treatment (HR= 2.02). Conclusions In the past decade, SSc patients have reached similar mortality of that expected in the Italian general population. Male gender, diffuse cutaneous involvement, comorbidities and PAH with or without ILD represent the main poor prognostic factors. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
19. Lung vascular changes as biomarkers of severity in systemic sclerosis–associated interstitial lung disease.
- Author
-
Bruni, Cosimo, Occhipinti, Mariaelena, Pienn, Michael, Camiciottoli, Gianna, Bartolucci, Maurizio, Bosello, Silvia Laura, Payer, Christian, Bálint, Zoltán, Larici, Anna Rita, Tottoli, Alessandra, Tofani, Lorenzo, Lorenzis, Enrico De, Lepri, Gemma, Bellando-Randone, Silvia, Spinella, Amelia, Giuggioli, Dilia, Masini, Francesco, Cuomo, Giovanna, Lavorini, Federico, and Colagrande, Stefano
- Subjects
- *
BIOMARKERS , *DIGITAL image processing , *INTERSTITIAL lung diseases , *SYSTEMIC scleroderma , *RETROSPECTIVE studies , *ACQUISITION of data , *PULMONARY function tests , *MEDICAL records , *DESCRIPTIVE statistics , *RESEARCH funding , *COMPUTED tomography - Abstract
Objectives It has recently become possible to assess lung vascular and parenchymal changes quantitatively in thoracic CT images using automated software tools. We investigated the vessel parameters of patients with SSc, quantified by CT imaging, and correlated them with interstitial lung disease (ILD) features. Methods SSc patients undergoing standard of care pulmonary function testing and CT evaluation were retrospectively evaluated. CT images were analysed for ILD patterns and total pulmonary vascular volume (PVV) extents with Imbio lung texture analysis. Vascular analysis (volumes, numbers and densities of vessels, separating arteries and veins) was performed with an in-house developed software. A threshold of 5% ILD extent was chosen to define the presence of ILD, and commonly used cut-offs of lung function were adopted. Results A total of 79 patients [52 women, 40 ILD, mean age 56.2 (s. d. 14.2) years, total ILD extent 9.5 (10.7)%, PVV/lung volume % 2.8%] were enrolled. Vascular parameters for total and separated PVV significantly correlated with functional parameters and ILD pattern extents. SSc-associated ILD (SSc-ILD) patients presented with an increased number and volume of arterial vessels, in particular those between 2 and 4 mm of diameter, and with a higher density of arteries and veins of <6 mm in diameter. Considering radiological and functional criteria concomitantly, as well as the descriptive trends from the longitudinal evaluations, the normalized PVVs, vessel numbers and densities increased progressively with the increase/worsening of ILD extent and functional impairment. Conclusion In SSc patients CT vessel parameters increase in parallel with ILD extent and functional impairment, and may represent a biomarker of SSc-ILD severity. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. Computer-Aided Quantification of Interstitial Lung Disease from High Resolution Computed Tomography Images in Systemic Sclerosis: Correlation with Visual Reader-Based Score and Physiologic Tests.
- Author
-
Salaffi, Fausto, Carotti, Marina, Bosello, Silvia, Ciapetti, Alessandro, Gutierrez, Marwin, Bichisecchi, Elisabetta, Giuseppetti, Gianmarco, and Ferraccioli, Gianfranco
- Subjects
- *
ACADEMIC medical centers , *CONFIDENCE intervals , *STATISTICAL correlation , *INTERSTITIAL lung diseases , *REGRESSION analysis , *PULMONARY function tests , *STATISTICS , *SYSTEMIC scleroderma , *TOMOGRAPHY , *DATA analysis , *RECEIVER operating characteristic curves , *DATA analysis software , *DESCRIPTIVE statistics - Abstract
Objective. To evaluate the performance of a computerized-aided method (CaM) for quantification of interstitial lung disease (ILD) in patients with systemic sclerosis and to determine its correlation with the conventional visual reader-based score (CoVR) and the pulmonary function tests (PFTs). Methods. Seventy-nine patients were enrolled. All patients underwent chest high resolution computed tomography (HRCT) scored by two radiologists adopting the CoVR. All HRCT images were then analysed by a CaM using a DICOM software. The relationships among the lung segmentation analysis, the readers, and the PFTs results were calculated using linear regression analysis and Pearson’s correlation. Receiver operating curve analysis was performed for determination of CaM extent threshold. Results. A strong correlation between CaM and CoVR was observed (P<0.0001). The CaM showed a significant negative correlation with forced vital capacity (FVC) (P<0.0001) and the single breath carbon monoxide diffusing capacity of the lung (DLco) (P<0.0001). A CaM optimal extent threshold of 20% represented the best compromise between sensitivity (75.6%) and specificity (97.4%). Conclusions. CaM quantification of SSc-ILD can be useful in the assessment of extent of lung disease and may provide reliable tool in daily clinical practice and clinical trials. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
21. β-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up.
- Author
-
De Santis, Maria, Inzitari, Rosanna, Bosello, Silvia L., Peluso, Giusy, Fanali, Chiara, Iavarone, Federica, Zizzo, Gaetano, Bocci, Mario, Cabras, Tiziana, Messana, Irene, Fuso, Leo, Varone, Francesco, Pagliari, Gabriella, Castagnola, Massimo, and Ferraccioli, Gianfranco
- Subjects
- *
THYMOSIN , *SCLERODERMA (Disease) , *CYTOSKELETON , *NEOVASCULARIZATION , *SYSTEMIC scleroderma , *BRONCHOALVEOLAR lavage - Abstract
Background: β-thymosins play roles in cytoskeleton rearrangement, angiogenesis, fibrosis and reparative process, thus suggesting a possible involvement in the pathogenesis of systemic sclerosis. The aim of the study was to investigate the presence of thymosins β4, β4 sulfoxide, and β10 in bronchoalveolar lavage fluid of scleroderma patients with interstitial lung disease and the relation of these factors with pulmonary functional and radiological parameters. Methods: β-thymosins concentrations were determined by Reverse Phase-High Performance Liquid Chromatography-Electrospray-Mass Spectrometry in the bronchoalveolar lavage fluid of 46 scleroderma patients with lung involvement and of 15 controls. Results: Thymosin β4, β4 sulfoxide, and β10 were detectable in bronchoalveolar lavage fluid of patients and controls. Thymosin β4 levels were significantly higher in scleroderma patients than in controls. In addition, analyzing the progression of scleroderma lung disease at one-year follow-up, we have found that higher thymosin β4 levels seem to have a protective role against lung tissue damage. Thymosin β4 sulfoxide levels were higher in the smokers and in the scleroderma patients with alveolitis. Conclusions: We describe for the first time β-thymosins in bronchoalveolar lavage fluid and their possible involvement in the pathogenesis of scleroderma lung disease. Thymosin β4 seems to have a protective role against lung tissue damage, while its oxidation product mirrors an alveolar inflammatory status. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
22. β-thymosins and interstitial lung disease: a study of a sclerodema cohort with a one-year follow-up.
- Author
-
De Santis, Maria, Inzitari, Rosanna, Bosello, Silvia L., Peluso, Giusy, Fanali, Chiara, Iavarone, Federica, Zizzo, Gaetano, Bocci, Mario, Cabras, Tiziana, Messana, Irene, Leo Fuso, Varone, Francesco, Pagliari, Gabriella, Castagnola, Massimo, and Ferraccioli, Gianfranco
- Subjects
- *
CYTOSKELETON formation , *NEOVASCULARIZATION , *FIBROSIS , *LUNG diseases , *IMMUNOTHERAPY - Abstract
Background: b-thymosins play roles in cytoskeleton rearrangement, angiogenesis, fibrosis and reparative process, thus suggesting a possible involvement in the pathogenesis of systemic sclerosis. The aim of the study was to investigate the presence of thymosins β4, β4 sulfoxide, and β10 in bronchoalveolar lavage fluid of scleroderma patients with interstitial lung disease and the relation of these factors with pulmonary functional and radiological parameters. Methods: β-thymosins concentrations were determined by Reverse Phase-High Performance Liquid Chromatography-Electrospray-Mass Spectrometry in the bronchoalveolar lavage fluid of 46 scleroderma patients with lung involvement and of 15 controls. Results: Thymosin β4, β4 sulfoxide, and β10 were detectable in bronchoalveolar lavage fluid of patients and controls. Thymosin β4 levels were significantly higher in scleroderma patients than in controls. In addition, analyzing the progression of scleroderma lung disease at one-year follow-up, we have found that higher thymosin β4 levels seem to have a protective role against lung tissue damage. Thymosin β4 sulfoxide levels were higher in the smokers and in the scleroderma patients with alveolitis. Conclusions: We describe for the first time β-thymosins in bronchoalveolar lavage fluid and their possible involvement in the pathogenesis of scleroderma lung disease. Thymosin β4 seems to have a protective role against lung tissue damage, while its oxidation product mirrors an alveolar inflammatory status. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
23. Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis
- Author
-
Zizzo, Gaetano, De Santis, Maria, Bosello, Silvia Laura, Fedele, Anna Laura, Peluso, Giusy, Gremese, Elisa, Tolusso, Barbara, and Ferraccioli, GianFranco
- Subjects
- *
SYNOVIAL fluid , *T cells , *INFLAMMATION , *BLOOD testing , *MONONUCLEOSIS , *RHEUMATOID arthritis - Abstract
Abstract: We analyzed peripheral blood (PB) and synovial fluid (SF) mononuclear cells from 16 rheumatoid arthritis (RA), 9 spondyloarthritis (SpA), 3 microcrystal arthritis patients, to define the presence of Th17 and Th1 and their relationship with inflammatory activity, and TCR-zeta chain and ZAP-70 levels. Th17 were significantly higher in SF than in PB and more abundant in microcrystal arthritis patients compared to the other groups. Irrespectively of the diagnosis, SF Th17 percentages correlated with joint (SF total leukocyte count, neutrophil percentage) and systemic (C reactive protein [CRP], fibrinogen, erythrocyte sedimentation rate) inflammation markers. SF Th1 percentages directly correlated with inflammation and disease activity (CRP, swollen joint count [SJC]) indices in SpA, but not in RA patients. These observations support the role of Th17 in the pathogenesis of inflammatory arthritides. The TCR-zetadim lymphocytes in SF were found to produce the highest amounts of cytokines including IL-17, whereas no ZAP-70 impairment was associated to Th17. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
24. Synovial B cells of rheumatoid arthritis express ZAP-70 which increases the survival and correlates with the inflammatory and autoimmune phenotype
- Author
-
Tolusso, Barbara, De Santis, Maria, Bosello, Silvia, Gremese, Elisa, Gobessi, Stefania, Cuoghi, Ilaria, Totaro, Michele C., Bigotti, Giulio, Rumi, Carlo, Efremov, Dimitar G., and Ferraccioli, Gianfranco
- Subjects
- *
B cells , *SYNOVIAL fluid , *BIOMARKERS , *IMMUNOREGULATION , *RHEUMATOID arthritis , *AUTOIMMUNITY , *PHENOTYPES , *INFLAMMATION , *PATIENTS - Abstract
Abstract: B cells have acquired an important role in the pathogenesis of rheumatoid arthritis (RA) since B cell depletion allowed to rescue patients poorly responders to TNFα blockers. This study focused on the involvement of ZAP-70 as a bio-marker of B cells immune activation in RA. ZAP-70 expression in synovial fluid (SF) B cells obtained from RA patients was increased compared to SF B cells of osteoarthritis (OA) patients. Moreover we found that ZAP-70 positive/CD38 positive and ZAP-70 positive/CD5 positive B cells were enriched in SF. The analysis of B cell apoptosis in vitro showed that the percentage of ZAP-70 negative B cells spontaneously undergoing apoptosis was significantly higher than ZAP-70 positive B cells. The ZAP-70 positive B cell ratio (SF/peripheral blood (PB)) showed a positive correlation with SF autoantibody levels and with local levels of BAFF and IL6. ZAP-70 positive B cells seem to define a subset characterized by increased survival and high relationship with local inflammation and autoimmunity. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
25. Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study.
- Author
-
Campochiaro, Corrado, Luca, Giacomo De, Lazzaroni, Maria Grazia, Zanatta, Elisabetta, Bosello, Silvia Laura, Santis, Maria De, Cariddi, Adriana, Bruni, Cosimo, Selmi, Carlo, Gremese, Elisa, Matucci-Cerinic, Marco, Doria, Andrea, Airò, Paolo, and Dagna, Lorenzo
- Subjects
- *
C-reactive protein , *IMMUNOSUPPRESSIVE agents , *INTERSTITIAL lung diseases , *MEDICAL cooperation , *NEUTROPENIA , *PATIENT safety , *RESEARCH , *SYSTEMIC scleroderma , *RITUXIMAB , *TREATMENT effectiveness , *BIOSIMILARS - Abstract
Objectives Recent data have shown a significant efficacy of rituximab (RTX) in SSc. An RTX biosimilar (RTX-B) is a more affordable option. We assessed the safety and efficacy of an RTX-B (CT-P10) in SSc. Methods SSc patients treated with RTX-B with at least 6 months of follow-up were retrospectively identified from six Italian referral centres. SSc patients naïve to RTX-B (RTX-Bn) or already treated with RTX originator and switched to an RTX-B (RTX-Bs) were evaluated. A comprehensive assessment of disease characteristics and organ involvement at baseline and after 6 months was obtained. Results Thirty-three SSc patients were selected: 29 (87.9%) females, mean age 51.6 years (s. d. 14.2), mean disease duration 9.8 years (s. d. 8.1); 21 (64.5%) with dcSSc, 20 (60.1%) anti-topoisomerase I, 7 (21.2%) anti-RNA polymerase III and 6 (18.2%) anti-centromere positive. Seventeen (51.5%) were RTX-Bn and 16 were on RTX-Bs (48.5%). RTX was introduced because of skin progression in 18 patients (54.5%), interstitial lung disease (ILD) worsening in 11 (33.3%) and arthritis in 12 (36.4%). All patients were previously treated with immunosuppressants. At RTX-B introduction, 21 (63.6%) patients were on concomitant immunosuppressants: 15 (71.4%) on MMF and 6 (28.6%) on MTX. Twenty-three (69.7%) were on low-dose steroids. After 6 months, a significant reduction of the modified Rodnan skin score (mRSS), 28-joint DAS and CRP was observed (P = 0.002, 0.005 and 0.008, respectively); the mRSS significantly improved both in RTX-Bn (P < 0.024) and RTX-Bs patients (P < 0.031). No significant changes were observed for lung function tests, either in the entire cohort or in the subgroup of ILD patients. Only one RTX-Bs patient experienced transient neutropenia. Conclusion Our data suggest that RTX-B can represent a cheaper option in SSc patients, as it is effective in improving skin and joint involvement and in stabilizing lung function. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
26. Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis.
- Author
-
Luca, Giacomo De, Campochiaro, Corrado, Santis, Maria De, Sartorelli, Silvia, Peretto, Giovanni, Sala, Simone, Canestrari, Giovanni, Lorenzis, Enrico De, Basso, Cristina, Rizzo, Stefania, Thiene, Gaetano, Palmisano, Anna, Esposito, Antonio, Selmi, Carlo, Gremese, Elisa, Bella, Paolo Della, Dagna, Lorenzo, and Bosello, Silvia Laura
- Subjects
- *
COMPARATIVE studies , *ECHOCARDIOGRAPHY , *HEART failure , *MAGNETIC resonance imaging , *CARDIOMYOPATHIES , *NONPARAMETRIC statistics , *SYSTEMIC scleroderma , *FIBROSIS , *RETROSPECTIVE studies , *DESCRIPTIVE statistics , *SYMPTOMS - Abstract
Objective To outline the clinical, histological and prognostic features of systemic sclerosis (SSc) endomyocardial biopsy-proven myocarditis with respect to those of diverse endomyocardial biopsy-proven virus-negative myocarditis (VNM). Methods We retrospectively analysed data from three cohorts of endomyocardial biopsy-proven myocarditis: SSc-related VNM (SSc-VNM); isolated VNM (i-VNM); and VNM related to other systemic autoimmune diseases (a-VNM). The degree of myocardial fibrosis was expressed as relative percentage and fibrotic score (0–3). Clinical data, cardiac enzymes, echocardiogram, 24 h ECG Holter and cardiac magnetic resonance were obtained at baseline and during follow-up. Non-parametric tests were used. Results We enrolled 12 SSc-VNM [11 females, mean age 49.3 (14.2) years; seven diffuse-SSc, five early-SSc], 12 i-VNM [12 females, mean age 47.7 (10.8) years] and 10 a-VNM [four females, mean age 48.4 (16.3) years] patients. SSc patients had higher degrees of myocardial fibrosis as assessed by both percentage [SSc-VNM: 44.8 (18.8)%; a-VNM: 28.6 (16.5)%; i-VNM: 24.9 (10.3)%; P = 0.019] and score [SSc-VNM: 2.3 (0.8); a-VNM: 1.4 (1.1); i-VNM: 1.2 (0.7); P = 0.002]. Myocardial fibrosis directly correlated with skin score (r = 0.625, P = 0.03) and number of ventricular ectopic beats on 24 h ECG Holter in SSc patients (r = 0.756, P = 0.01). Dyspnoea class was higher at presentation in SSc-VNM patients (P = 0.041) and we found heart failure only in SSc patients (25%) (P = 0.05). At cardiac magnetic resonance, myocardial oedema was nearly undetectable in SSc-VNM patients compared with others (P = 0.02). All patients received immunosuppressive treatment. The number of patients who died during follow-up due to cardiac complications was significantly higher in SSc-VNM patients (50%), as compared with a-VNM (0%) and i-VNM (8.3%) patients (P = 0.006). Patients who died during follow-up had higher degrees of myocardial fibrosis [52.2 (11.6)% vs 27.5 (12.9)%, P = 0.024; fibrotic score: 2.83 (0.41) vs 1.4 (0.9), P < 0.001]. Conclusion SSc has unique clinical and histological features, as it tends to present more frequently with heart failure and a higher dyspnoea class and to show higher degrees of myocardial fibrosis. These specific features are paralleled by a worse cardiac prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
27. Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study.
- Author
-
Negrini, Simone, Magnani, Ottavia, Matucci-Cerinic, Marco, Carignola, Renato, Data, Valeria, Montabone, Erika, Santaniello, Alessandro, Adorni, Giuditta, Murdaca, Giuseppe, Puppo, Francesco, Indiveri, Francesco, Della Rossa, Alessandra, D'Ascanio, Anna, Barsotti, Simone, Giuggioli, Dilia, Ferri, Clodoveo, Lumetti, Federica, Bosello, Silvia Laura, Canestrari, Giovanni, and Bellando Randone, Silvia
- Subjects
- *
RAYNAUD'S disease , *SYSTEMIC scleroderma , *PRODUCTION scheduling , *THERAPEUTICS , *VASCULAR diseases , *MEDICAL records - Abstract
Vasculopathy is a crucial feature of systemic sclerosis (SSc), and Raynaud's phenomenon (RP) and digital ulcers (DU) have a deep impact on the quality of patients' life. The management of vascular disease can be challenging for the clinician because of the suboptimal tolerability of the treatments and lack of consensus on the best therapeutic approach. Intravenous iloprost, a synthetic analogue of prostacyclin, is broadly used for the treatment of RP and ischemic ulcers secondary to SSc. However, no standardized protocol on iloprost use is currently available and, consequently, the management of this treatment is largely based on the experience of each single center. The PROSIT project is an observational, multicenter study aiming to investigate the current treatments for SSc vasculopathy, the use of prostanoids, with special regard to iloprost, and the perception of the treatment from a patient's perspective. The study was conducted on a cohort of 346 patients from eight Italian centers and included a structured survey addressed to physicians, data collected from patient's medical records and two patient-administered questionnaires assessing the level of satisfaction, tolerability and perception of the efficacy of Iloprost. PROSIT data confirmed that in the contest of SSc iloprost represents the first-line choice for the management of severe RP and DU. Moreover, it is a well-tolerated treatment as reported by patients' experience. Although a standard protocol for the treatment of SSc-related vasculopathy is lacking, PROSIT study identified different therapeutic approaches largely supported by tertiary Italian centers. Further studies are needed in order to optimize the best treatment for SSc vascular diseases, in particular to improve the best iloprost schedule management. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
28. European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis.
- Author
-
Abignano, Giuseppina, Blagojevic, Jelena, Bissell, Lesley-Anne, Dumitru, Raluca B, Eng, Sookhoe, Allanore, Yannick, Avouac, Jerome, Bosello, Silvia, Denton, Christopher P, Distler, Oliver, Ferraccioli, Gianfranco, Jordan, Suzana, Matucci-Cerinic, Marco, Ong, Voon, Messenger, Michael, Hutchinson, Michelle, Buch, Maya H, Emery, Paul, and Galdo, Francesco Del
- Subjects
- *
CIRRHOSIS of the liver , *SYSTEMIC scleroderma , *RESEARCH , *ALGORITHMS , *BIOMARKERS , *COLLAGEN , *HYALURONIC acid , *LUNGS , *RESEARCH methodology , *MEDICAL cooperation , *MULTIVARIATE analysis , *RESPIRATORY measurements , *SEX distribution , *SYMPTOMS , *SEVERITY of illness index , *DATA analysis software , *MATRIX metalloproteinases , *DIAGNOSIS - Abstract
Objectives To validate enhanced liver fibrosis (ELF) test and its components—amino-terminal propeptide of procollagen type III (PIIINP), tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) and HA—as biomarkers of fibrosis in SSc in an independent, international, multicentre cohort. Methods Two hundred and fifty-four SSc patients from six Rheumatology Centres were included. Sera were collected and stored according to EUSTAR biobanking recommendations and analysed through automated high throughput diagnostics. Statistical analysis was performed with SPSS software. Results Two hundred and forty-seven SSc patients (mean age 55.7 ± 13.9 years, 202 F) were analysed. ELF score, TIMP-1 and PIIINP levels were higher in males (P = 0.0197, P = 0.0107, P = 0.0108 respectively) and in dcSSc (P = 0.001, P = 0.0008, P < 0.0001 respectively). ELF score and the single markers significantly correlated with modified Rodnan skin score (r = 0.37, P < 0.0001), disease activity and severity (P < 0.0001 for all markers, except for HA P = 0.0001) and inversely with forced vital capacity, (FVC) % (TIMP-1, r = −0.21, P = 0.0012; PIIINP, r = −0.26, P = 0.0001), TLC% (ELF score, r = −0.20, P = 0.0036; TIMP-1, r = −0.32, P < 0.0001; PIIINP, r = −0.28, P < 0.0001), diffusion capacity of the lung for carbon monoxide (DLCO) % (P < 0.0001 for all markers, except for HA P = 0.0115). Multivariate analysis indicated that age (P < 0.001), modified Rodnan skin score (P < 0.001) and DLCO% (P = 0.005) were independently associated with ELF score. Conclusion Between the first and this validation studies, the value of the ELF score as independent marker of skin and lung involvement in SSc is confirmed in 457 patients. A longitudinal study is on-going to identify an SSc specific algorithm with predictive value for skin and lung progression. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
29. Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients.
- Author
-
De Lorenzis, Enrico, Parente, Paolo, Natalello, Gerlando, Soldati, Salvatore, Bosello, Silvia Laura, Barbara, Andrea, Sorge, Chiara, Axelrod, Svetlana, Verardi, Lucrezia, Cerasuolo, Pier Giacomo, Peluso, Giusy, Gemma, Antonella, Davoli, Marina, Biliotti, Donatella, Bruzzese, Vincenzo, Goletti, Mauro, Di Martino, Mirko, and D'Agostino, Maria Antonietta
- Subjects
- *
RHEUMATISM , *COVID-19 , *PUBLIC health , *CLASSIFICATION , *AUTOIMMUNE diseases - Published
- 2023
- Full Text
- View/download PDF
30. Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic.
- Author
-
De Lorenzis, Enrico, Natalello, Gerlando, Verardi, Lucrezia, Cerasuolo, Pier Giacomo, Gigante, Laura, D'Agostino, Maria Antonietta, and Bosello, Silvia Laura
- Subjects
- *
COVID-19 , *COVID-19 pandemic , *RAYNAUD'S disease , *SYSTEMIC scleroderma , *SCLERODERMA (Disease) - Abstract
Intravenous iloprost is currently recommended in the treatment of Raynaud's phenomenon (RP) refractory to oral therapy and of digital ulcers (DUs) related to systemic sclerosis (SSc). In real-life practice there is a huge heterogeneity about the Iloprost regimens used. A survey was carried out on SSc patients that interrupted Iloprost infusion to compare acral vascular symptoms just before Iloprost withdrawal and just after the missed infusion. Severity, and frequency of RP, new DUs onset or aggravation of those pre-existing were reported. Last available capillaroscopic images were also evaluated. The analysis includes 50 patients. After iloprost withdrawal, 11 patients reported a RP worsening because of enhanced intensity (p = 0.007). Only 8 patients of them also complained of an increased frequency (p = 0.07). None of the patients experienced digital ulcers for the first-time during quarantine. Among the 27 patients with a history of digital ulcers, 9 reported worsening and 7 recurrence of DUs. Overall, 17 patients (34.0 %) complained of a worsening of SSc vascular acral manifestations, namely RP or DUs. Reduced capillary density was associated with RP worsening, in particular, each unit increase of capillary density corresponds to an average 44 % decrease in the odds of RP worsening (OR 0.56, CI 95 % 0.36–0.97, p = 0.037). As for RP worsening, the aggravation of DU was associated with a lower capillary density. Low capillary density can predict a worsening of both RP and DUs in controlled quarantine conditions within a month after iloprost discontinuation in SSc patients. • Coronavirus pandemic provided unrepeatable circumstances close to an experimental condition to assesses the effect of iloprost withdrawal in scleroderma. • Low capillary density at capillaroscopy can predict an early worsening of both Raynaud's phenomenon and digital ulcers after iloprost discontinuation. • Capillaroscopy could be used to personalize Iloprost regimens in scleroderma patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
31. Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature.
- Author
-
Ferri, Clodoveo, De Angelis, Rossella, Giuggioli, Dilia, Bajocchi, Gianluigi, Dagna, Lorenzo, Zanframundo, Giovanni, Foti, Rosario, Cacciapaglia, Fabio, Cuomo, Giovanna, Ariani, Alarico, Rosato, Edoardo, Guiducci, Serena, Girelli, Francesco, Riccieri, Valeria, Zanatta, Elisabetta, Bosello, Silvia, Cavazzana, Ilaria, Ingegnoli, Francesca, De Santis, Maria, and Murdaca, Giuseppe
- Subjects
- *
SYSTEMIC scleroderma , *LITERATURE , *SJOGREN'S syndrome , *LITERATURE reviews , *PHENOTYPES , *INTERSTITIAL cystitis - Abstract
Systemic sclerosis (SSc) is characterized by a complex etiopathogenesis encompassing both host genetic and environmental -infectious/toxic- factors responsible for altered fibrogenesis and diffuse microangiopathy. A wide spectrum of clinical phenotypes may be observed in patients' populations from different geographical areas. We investigated the prevalence of specific clinical and serological phenotypes in patients with definite SSc enrolled at tertiary referral centres in different Italian geographical macro-areas. The observed findings were compared with those reported in the world literature. The clinical features of 1538 patients (161 M, 10.5%; mean age 59.8 ± 26.9 yrs.; mean disease duration 8.9 ± 7.7 yrs) with definite SSc recruited in 38 tertiary referral centres of the SPRING (Systemic sclerosis Progression INvestiGation Group) registry promoted by Italian Society of Rheumatology (SIR) were obtained and clustered according to Italian geographical macroareas. Patients living in Southern Italy were characterized by more severe clinical and/or serological SSc phenotypes compared to those in Northern and Central Italy; namely, they show increased percentages of diffuse cutaneous SSc, digital ulcers, sicca syndrome, muscle involvement, arthritis, cardiopulmonary symptoms, interstitial lung involvement at HRCT, as well increased prevalence of serum anti-Scl70 autoantibodies. In the same SSc population immunusppressive drugs were frequently employed. The review of the literature underlined the geographical heterogeneity of SSc phenotypes, even if the observed findings are scarcely comparable due to the variability of methodological approaches. The phenotypical differences among SSc patients' subgroups from Italian macro-areas might be correlated to genetic/environmental co-factors, and possibly to a not equally distributed national network of information and healthcare facilities. • Higher prevalence of severe clinical/serological SSc phenotypes in Southern, compared to other Italian macro-areas. • The updated review of the world literature supports the geographical heterogeneity of SSc phenotypes. • Possible role of genetic/environmental etiopathogenetic factors. • Possible role of not uniform network of specialized territorial referral centers. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
32. Memory B cell subsets and plasmablasts are lower in early than in long-standing Rheumatoid Arthritis.
- Author
-
Fedele, Anna Laura, Tolusso, Barbara, Gremese, Elisa, Bosello, Silvia Laura, Carbonella, Angela, Canestri, Silvia, and Ferraccioli, Gianfranco
- Subjects
- *
B cells , *RHEUMATOID arthritis , *MEMORY , *ANTIGENS , *BIOMARKERS - Abstract
Background Alterations of B cell subset distribution have been described in the peripheral blood (PB) of rheumatoid arthritis (RA) patients, but no data are available on differences between the onset and the established phases of the disease. The purpose of the study was to clarify whether a peculiar distribution of B cell subsets characterizes RA onset, thus leading to a more favorable clinical response to treatment, and to evaluate the possible association of a particular B cell subpopulation with response to therapy. Results 122 RA patients were enrolled: 25 had symptom duration less than 3 months and were defined as having "very early RA" (VERA), and 43 had symptom duration from more than 3 months up to one year (early-RA: ERA). The other 54 RA patients had long-standing RA (LSRA). At baseline and at 6-month follow-up visit peripheral blood samples were collected and analyzed by flow cytometry for the distribution of circulating B cell subsets by staining with surface markers CD45, CD19, CD38, CD27 and IgD and intracellular marker ZAP70. VERA and ERA patients showed higher percentages and absolute counts of circulating antigen inexperienced naïve B cells (IgD + CD27-) and lower percentages and absolute numbers of double negative (IgD-CD27-) memory B cells and plasmablasts (CD38 + CD27+) compared to LSRA patients. At the multivariate analysis, a higher frequency of naïve B cells (IgD + CD27-) at baseline arose as significant predictor of CDAI remission, together with "having VERA disease" and a low disease activity at baseline. Conclusions The onset of RA is characterized by higher percentages and absolute numbers of naïve B cells and lower numbers of plasmablasts and double negative memory B cells compared to established RA. Naïve B cells could represent a promising biomarker of outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
33. β-Thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up.
- Author
-
De Santis, Maria, Inzitari, Rosanna, Bosello, Silvia L, Peluso, Giusy, Fanali, Chiara, Iavarone, Federica, Zizzo, Gaetano, Bocci, Mario, Cabras, Tiziana, Messana, Irene, Fuso, Leo, Varone, Francesco, Pagliari, Gabriella, Castagnola, Massimo, and Ferraccioli, Gianfranco
- Abstract
Background: β-thymosins play roles in cytoskeleton rearrangement, angiogenesis, fibrosis and reparative process, thus suggesting a possible involvement in the pathogenesis of systemic sclerosis. The aim of the study was to investigate the presence of thymosins β4, β4 sulfoxide, and β10 in bronchoalveolar lavage fluid of scleroderma patients with interstitial lung disease and the relation of these factors with pulmonary functional and radiological parameters.Methods: β-thymosins concentrations were determined by reverse phase-high performance liquid chromatography-electrospray-mass spectrometry in the bronchoalveolar lavage fluid of 46 scleroderma patients with lung involvement and of 15 controls.Results: Thymosin β4, β4 sulfoxide, and β10 were detectable in bronchoalveolar lavage fluid of patients and controls. Thymosin β4 levels were significantly higher in scleroderma patients than in controls. In addition, analyzing the progression of scleroderma lung disease at one-year follow-up, we have found that higher thymosin β4 levels seem to have a protective role against lung tissue damage. Thymosin β4 sulfoxide levels were higher in the smokers and in the scleroderma patients with alveolitis.Conclusions: We describe for the first time β-thymosins in bronchoalveolar lavage fluid and their possible involvement in the pathogenesis of scleroderma lung disease. Thymosin β4 seems to have a protective role against lung tissue damage, while its oxidation product mirrors an alveolar inflammatory status. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
34. B-Cell Subsets in the Joint Compartments of Seropositive and Seronegative Rheumatoid Arthritis (RA) and No-RA Arthritides Express Memory Markers and ZAP70 and Characterize the Aggregate Pattern Irrespectively of the Autoantibody Status.
- Author
-
Michelutti, Alessandro, Gremese, Elisa, Morassi, Francesca, Petricca, Luca, Arena, Vincenzo, Tolusso, Barbara, Alivernini, Stefano, Peluso, Giusy, Bosello, Silvia Laura, and Ferraccioli, Gianfranco
- Subjects
- *
B cells , *RHEUMATOID arthritis , *AUTOANTIBODIES , *SYNOVIAL fluid , *RHEUMATOID factor , *TUMOR necrosis factors - Abstract
The aim of the present study was to determine whether different subsets of B cells characterize synovial fluid (SF) or synovial tissue (ST) of seropositive or seronegative rheumatoid arthritis (RA) with respect to the peripheral blood (PB). PB, SF and ST of 14 autoantibody (AB)-positive (rheumatoid factor [RF]-IgM, RF-IgA, anti-citrullinated peptide [CCP]), 13 negative RA and 13 no-RA chronic arthritides were examined for B-cell subsets (Bm1-Bm5 and IgD-CD27 classifications), zeta-associated protein kinase-70 (ZAP70) expression on B cells and cytokine levels (interleukin [IL]-1β, tumor necrosis factor [TNF]-α, IL-6, IL-8 and monocyte chemotactic protein [MCP]-1). Synovial tissues were classified as aggregate and diffuse patterns. No differences were found in B-cell percentages or in subsets in PB and SF between AB+ and AB- RA and no-RA. In both AB+ and AB- RA (and no-RA), the percentage of CD19+/ZAP70+ was higher in SF than in PB (AB+: P = 0.03; AB-: P = 0.01; no-RA: P = 0.01). Moreover, SF of both AB+ and AB- RA (and no-RA) patients was characterized by a higher percentage of IgD-CD27+ and IgD-CD27- B cells and lower percentage of IgD+CD27- (P < 0.05) B cells compared to PB. In SF, ZAP70 positivity is more represented in B cell CD27+/IgD-/CD38-. The aggregate synovitis pattern was characterized by higher percentages of Bm5 cells in SF compared with the diffuse pattern (P = 0.05). These data suggest that no difference exists between AB+ and AB- in B-cell subset compartmentalization. CD27+/IgD-/ZAP70+ memory B cells accumulate preferentially in the joints of RA, suggesting a dynamic maturation of the B cells in this compartment. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
35. PTPN22 1858C>T Polymorphism Distribution in Europe and Association with Rheumatoid Arthritis: Case-Control Study and Meta-Analysis.
- Author
-
Totaro, Michele Ciro, Tolusso, Barbara, Napolioni, Valerio, Faustini, Francesca, Canestri, Silvia, Mannocci, Alice, Gremese, Elisa, Bosello, Silvia Laura, Alivernini, Stefano, and Ferraccioli, Gianfranco
- Subjects
- *
GENETIC polymorphisms , *RHEUMATOID arthritis , *CASE-control method , *AUTOANTIBODIES , *META-analysis , *GENE frequency , *COMPARATIVE studies - Abstract
Objective: The PTPN22 rs2476601 polymorphism is associated with rheumatoid arthritis (RA); nonetheless, the association is weaker or absent in some southern European populations. The aim of the study was to evaluate the association between the PTPN22 rs2476601 polymorphism and RA in Italian subjects and to compare our results with those of other European countries, carrying out a meta-analysis of European data. Methods: A total of 396 RA cases and 477 controls, all of Italic ancestry, were genotyped for PTPN22 rs2476601 polymorphism. Patients were tested for autoantibodies positivity. The meta-analysis was performed on 23 selected studies. Results: The PTPN22 T1858 allele was significantly more frequent in RA patients compared to controls (5.7% vs. 3.7%, p = 0.045). No clear relationship arose with the autoantibodies tested. The 1858T allele frequency in Italian RA patients was lower than the one described in northern European populations and similar to the frequency found in Spain, Turkey, Greece, Tunisia. A clear-cut North-South gradient arose from the analysis. Conclusions: The PTPN22 T1858 allele is associated with RA in the Italian population. A North-South gradient of the allele frequency seems to exist in Europe, with a lower prevalence of the mutation in the Mediterranean area. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
36. Proteomic approaches to Sjögren's syndrome: A clue to interpret the pathophysiology and organ involvement of the disease
- Author
-
Ferraccioli, Gianfranco, De Santis, Maria, Peluso, Giusy, Inzitari, Rosanna, Fanali, Chiara, Bosello, Silvia Laura, Iavarone, Federica, and Castagnola, Massimo
- Subjects
- *
SJOGREN'S syndrome , *PROTEOMICS , *PATHOLOGICAL physiology , *AUTOIMMUNE diseases , *BIOMARKERS , *POST-translational modification , *BIOPSY - Abstract
Abstract: Sjögren''s syndrome (SS) is a chronic, inflammatory, autoimmune disease characterized by lymphocytic infiltration of the exocrine glands leading to qualitatively altered and diminished or absent salivary and lachrymal secretion, and by marked B-cell hyperreactivity. Many efforts have been made to define a panel of salivary and lachrymal markers helpful to design diagnostic tests able to replace blood tests and tissue biopsies for the diagnosis of primary and secondary SS. Several proteomic-based studies have indicated that a number of proteins and peptides can be considered SS biomarkers, being 2–3-fold up- or down-regulated compared to normal subject or having an exclusive presence in the saliva or tears of SS patients. Unfortunately, several factors make it difficult to define a comprehensive salivary and lachrymal panel of markers of SS, as the lack of a comprehensive proteomic analysis of human tears and saliva of healthy subjects, the lack of uniform protocols to collect and treat these samples, and the high grade of posttranslational modification of the proteins in these fluids. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
37. Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios.
- Author
-
Pietrapertosa, Donatello, Tolusso, Barbara, Gremese, Elisa, Papalia, Maria Concetta, Bosello, Silvia Laura, Peluso, Giusy, Petricca, Luca, Michelutti, Alessandro, Faustini, Francesca, Fedele, Anna Laura, and Ferraccioli, Gianfranco
- Subjects
- *
IMMUNOGLOBULINS , *RHEUMATOID arthritis , *AUTOIMMUNE diseases , *INFLAMMATION , *BIOLOGICAL assay - Abstract
Background: The goal of our study was to evaluate the diagnostic performance of the anti-cyclic citrullinated peptide 2 (anti-CCP2) assay in patients with autoimmune and inflammatory disorders. Methods: We tested the specificity and sensitivity of anti-CCP2 antibodies measured by ELISA in 787 patients with rheumatoid arthritis (RA), 1024 patients with other autoimmune/inflammatory rheumatic disease and 401 subjects without autoimmune rheumatic disease. The optimal cut-off value was defined as the value with the highest diagnostic accuracy (receiver operating characteristic curve analysis). Interval-specific likelihood ratios (LRs) were calculated for each range bounded by defined anti-CCP2 values. Results: To distinguish between patients with RA and controls, the cut-off value with the highest diagnostic accuracy for anti-CCP2 was 2.8 U/mL. Comparing the optimal cut-off value for anti-CCP2 to that recommended by the manufacturer (5.0 U/mL), an increase in prevalence between the proportions of test-positive patients was found for RA, undifferentiated connective tissue disease and undifferentiated arthritis. Evaluating interval-specific LRs for the selected ranges bound by two anti-CCP2 values, in RA and diseased controls, the LRs were 0.40 for values <5.0 U/mL, 6.66 for 5.0–15.0 U/mL, 27.01 for 15.1–30.0 U/mL and 28.89 for >30.0 U/mL. Conclusions: The cut-off value of 2.8 U/mL for anti-CCP2 has the highest diagnostic accuracy. A value of anti-CCP2 >15 U/mL is associated with an increase in the likelihood of RA disease. Clin Chem Lab Med 2010;48:829–34. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
38. Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone.
- Author
-
Carbonella, Angela, Berardi, Giorgia, Petricca, Luca, Biscetti, Federico, Alivernini, Stefano, Bosello, Silvia Laura, Fedele, Anna Laura, Ferraccioli, Gianfranco, and Gremese, Elisa
- Subjects
- *
ARTERITIS , *THERAPEUTICS , *HORMONE therapy , *CORTICOSTEROIDS , *BIOPSY , *COMBINATION drug therapy , *GIANT cell arteritis , *IMMUNOSUPPRESSION , *DATA analysis software , *DESCRIPTIVE statistics - Abstract
A letter to the editor is presented in response to research focusing upon the treatment of giant cell arteritis.
- Published
- 2016
- Full Text
- View/download PDF
39. Residual minimal disease activity in rheumatoid arthritis: a simple definition through an in-depth statistical analysis of the major outcome.
- Author
-
Pietrapertosa, Donatello, Salaffi, Fausto, Peluso, Giusy, Bosello, Silvia L., Fedele, Anna L., Cuoghi, Ilaria, Michelutti, Alessandro, Gremese, Elisa, and Ferraccioli, Gianfranco F.
- Subjects
- *
MEDICAL research , *RHEUMATOID arthritis , *MEDICAL statistics , *HEALTH status indicators , *CLINICAL trials - Abstract
Objective. To obtain the simplest definition of minimal disease activity (MDA) and to compare it with published proposed definitions of MDA in patients with RA.Methods. Two hundred and fourteen patients with long-standing RA (LSRA) were evaluated for clinical and laboratory parameters. Factor analysis was performed to remove redundant variables included in the core set measure for MDA definition stated by the OMERACT. Receiver operating characteristic (ROC) curves analysis allowed to obtain optimal cut-off predictors of a 28-joint disease activity score (DAS28) ⩽2.85. These were tested in 112 LSRA and 95 early-onset RA (ERA) patients.Results. Factor and ROC curve analysis showed that the best predictors of a DAS28 ⩽ 2.85 in LSRA cohort were: (i) ESR <20 mm/h (sensitivity: 80%, specificity: 54%); (ii) swollen joint count (out of 28) ⩽2 (sensitivity: 95%, specificity: 74%); (iii) patient global assessment (0–100) ⩽15 (sensitivity: 78%, specificity: 78%); and (iv) HAQ (0–3) ⩽0.5 (sensitivity: 91%, specificity: 61%). To each of these four criteria we assigned a value of 1 when it was satisfied (score ranging: 0–4). The cut-off with the highest overall accuracy for identifying RA patients with DAS28 ⩽ 2.85 was a score ⩾3. We adopted these four parameters in order to define the residual MDA (RMDA). Comparing RMDA criteria, in distinct 112 LSRA and 95 ERA patients, with OMERACT, Simplified Disease Activity Index and Clinical Disease Activity Index definitions of MDA, we found a good agreement in the LSRA cohort and moderate agreement in the ERA cohort.Conclusions. HAQ, PaGA, SJC28 and ESR allow identification of RA patients with an RMDA. The RMDA criteria behaves similarly to OMERACT definitions, but appears more simple and feasible. [ABSTRACT FROM PUBLISHER]
- Published
- 2009
- Full Text
- View/download PDF
40. Kingella kingae Intrauterine Infection: An Unusual Cause of Chorioamnionitis and Miscarriage in a Patient with Undifferentiated Connective Tissue Disease.
- Author
-
Bonasoni, Maria Paola, Palicelli, Andrea, Dalla Dea, Giulia, Comitini, Giuseppina, Pazzola, Giulia, Russello, Giuseppe, Bertoldi, Graziella, Bardaro, Marcellino, Zuelli, Claudia, Carretto, Edoardo, and Bosello, Silvia Laura
- Subjects
- *
CONNECTIVE tissue diseases , *CHORIOAMNIONITIS , *SYSTEMIC lupus erythematosus , *MISCARRIAGE , *PREMATURE rupture of fetal membranes , *INFECTIOUS arthritis - Abstract
Kingella kingae is a Gram-negative coccobacillus belonging to the Neisseriaceae family. In children less than 4 years old, K. kingae invasive infection can induce septic arthritis and osteomyelitis, and more rarely endocarditis, meningitis, ocular infections, and pneumonia. In adults, it may be a cause of endocarditis. To date, K. kingae acute chorioamnionitis (AC) leading to preterm rupture of membranes (PPROM) and miscarriage has never been reported. Herein, we describe a case of intrauterine fetal death (IUFD) at 22 weeks' gestation due to K. kingae infection occurred in a patient affected by undifferentiated connective tissue disease (UCTD) in lupus erythematosus systemic (LES) evolution with severe neutropenia. K. kingae was isolated in placental subamnionic swab and tissue cultures as well as fetal ear, nose, and pharyngeal swabs. Placental histological examination showed necrotizing AC and funisitis. In the fetus, neutrophils were observed within the alveoli and in the gastrointestinal lumen. Maternal medical treatment for UCTD was modified according to the K. kingae invasive infection. In the event of IUFD due to AC, microbiological cultures on placenta and fetal tissues should always be carried out in order to isolate the etiologic agent and target the correct medical treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
41. Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement.
- Author
-
Natalello, Gerlando, De Luca, Giacomo, Gigante, Laura, Campochiaro, Corrado, De Lorenzis, Enrico, Verardi, Lucrezia, Paglionico, Annamaria, Petricca, Luca, Martone, Anna Maria, Calvisi, Stefania, Ripa, Marco, Cavalli, Giulio, Della-Torre, Emanuel, Tresoldi, Moreno, Landi, Francesco, Bosello, Silvia Laura, Gremese, Elisa, and Dagna, Lorenzo
- Subjects
- *
COVID-19 , *COVID-19 testing , *HOSPITAL admission & discharge , *ENDOTHELIUM diseases , *SCLERODERMA (Disease) - Abstract
Increasing evidence points to endothelial dysfunction as a key pathophysiological factor in coronavirus disease-2019 (COVID-19). No specific methods have been identified to predict, detect and quantify the microvascular alterations during COVID-19. Our aim was to assess microvasculature through nailfold videocapillaroscopy (NVC) in COVID-19 patients. We performed NVC in patients with a confirmed diagnosis of COVID-19 pneumonia. Elementary alterations were reported for each finger according to a semi-quantitative score. Capillary density, number of enlarged and giant capillaries, number of micro-hemorrhages and micro-thrombosis (NEMO score) were registered. We enrolled 82 patients (mean age 58.8 ± 13.2 years, male 68.3%) of whom 28 during the hospitalization and 54 after recovery and hospital discharge. At NVC examination we found abnormalities classifiable as non-specific pattern in 53 patients (64.6%). Common abnormalities were pericapillary edema (80.5%), enlarged capillaries (61.0%), sludge flow (53.7%), meandering capillaries and reduced capillary density (50.0%). No pictures suggestive of scleroderma pattern have been observed. Acute COVID-19 patients, compared to recovered patients, showed a higher prevalence of hemosiderin deposits as a result of micro-hemorrhages (P =.027) and micro-thrombosis (P <.016), sludge flow (P =.001), and pericapillary edema (P <.001), while recovered patients showed a higher prevalence of enlarged capillaries (P <.001), loss of capillaries (P =.002), meandering capillaries (P <.001), and empty dermal papillae (P =.006). COVID-19 patients present microvascular abnormalities at NVC. Currently ill and recovered subjects are characterized by a different distribution of elementary capillaroscopic alterations, resembling acute and post-acute microvascular damage. Further studies are needed to assess the clinical relevance of NVC in COVID-19. • We assessed and accurately described peripheral microvasculature in COVID-19 patients through nailfold videocapillaroscopy. • Capillary alterations at the nailfold bed suggest a broad COVID-related microvascular involvement. • Different alterations in acutely-ill and recovered patients resemble a transition from acute to post-acute injury. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
42. What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19?
- Author
-
De Lorenzis, Enrico, Natalello, Gerlando, Gigante, Laura, Verardi, Lucrezia, Bosello, Silvia Laura, and Gremese, Elisa
- Subjects
- *
COVID-19 , *INTERSTITIAL lung diseases , *DERMATOMYOSITIS , *PNEUMOMEDIASTINUM , *MEDICAL sciences , *SARS-CoV-2 - Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.